Holmusk and Otsuka team up to develop real-world evidence based behavioural health platform. CONTEXT: Commercial announcement that Holmusk and Otsuka are partnering to develop one of the largest real-world evidence Continue Reading
Rising prevalence of depression and anxiety are major drivers in the increased demand for psychedelic drugs CONTEXT: This article reviews the increasing demand for psychedelic drugs in the treatment of Continue Reading
The role of family health history in predicting midlife chronic disease outcomes. CONTEXT: This longitudinal real-world research study published in the American Journal of Preventive Medicine looked at the relevance Continue Reading
Retrospective review of healthcare costs associated with treatment-resistant depression (TRD) in Italy CONTEXT: Published in the ClinicoEconomics and Outcomes Research Journal, this retrospective review of around 6 million administrative database Continue Reading
CBD-Rich cannabis products associated with improvements for patients with severe pain, anxiety and depression. CONTEXT: Publication of a real-world evidence study in the Journal of Cannabis Research points to improvements Continue Reading
Prospective observational study of clozapine in the treatment of schizophrenia. CONTEXT: 189 patients were included in this 5-year prospective observational study which looked at the safety and tolerability profile when Continue Reading
CONTEXT: Who knew that mood altering compounds might alter your mood – but in a good way? We’ve included this nice coffee break moment article on the renewed interest in Continue Reading
CONTEXT: Continuing this years theme of presenting RWR posters alongside traditional RCTs, Teva showed off their AJOVY (fremanezumab-vfrm) treatment for migraine at the American Headache Society annual meeting. Also included Continue Reading
CONTEXT: An interview article with a UK based company looking to bring “natural” psilocybin medicines to market through RWE studies and dodge the usual RCT regulatory routes. One to watch Continue Reading
CONTEXT: A different approach to spotting early onset dementia, utilising driving behaviour from a 4 year period in the US. As a long-term advocate of better diagnostic tools in dementia Continue Reading
